GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanai Health Industry Group Co Ltd (HKSE:01889) » Definitions » Cash Conversion Cycle

Sanai Health Industry Group Co (HKSE:01889) Cash Conversion Cycle : 36.47 (As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Sanai Health Industry Group Co Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Sanai Health Industry Group Co's Days Sales Outstanding for the six months ended in Jun. 2024 was 85.4.
Sanai Health Industry Group Co's Days Inventory for the six months ended in Jun. 2024 was 31.02.
Sanai Health Industry Group Co's Days Payable for the six months ended in Jun. 2024 was 79.95.
Therefore, Sanai Health Industry Group Co's Cash Conversion Cycle (CCC) for the six months ended in Jun. 2024 was 36.47.


Sanai Health Industry Group Co Cash Conversion Cycle Historical Data

The historical data trend for Sanai Health Industry Group Co's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanai Health Industry Group Co Cash Conversion Cycle Chart

Sanai Health Industry Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 133.71 121.16 22.63 23.55 35.05

Sanai Health Industry Group Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.41 19.06 34.97 36.47 11.42

Competitive Comparison of Sanai Health Industry Group Co's Cash Conversion Cycle

For the Drug Manufacturers - Specialty & Generic subindustry, Sanai Health Industry Group Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanai Health Industry Group Co's Cash Conversion Cycle Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanai Health Industry Group Co's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Sanai Health Industry Group Co's Cash Conversion Cycle falls into.


;
;

Sanai Health Industry Group Co Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Sanai Health Industry Group Co's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=43.46+1.96-21.87
=23.55

Sanai Health Industry Group Co's Cash Conversion Cycle for the quarter that ended in Jun. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=85.4+31.02-79.95
=36.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanai Health Industry Group Co  (HKSE:01889) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Sanai Health Industry Group Co Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Sanai Health Industry Group Co's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanai Health Industry Group Co Business Description

Traded in Other Exchanges
N/A
Address
57 Hung To Road, Unit 5, 7th Floor, Nanyang Plaza, Kwun Tong, Kowloon, Hong Kong, HKG
Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products include development, manufacturing, marketing, and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives the majority of its revenue from the PRC.
Executives
Zhi Shaohuan 2101 Beneficial owner
Jiang Hengguang
Yang Youju 2201 Interest of corporation controlled by you
Yuan Chaoyang 2101 Beneficial owner
Cyber Success Global Investments Limited 2101 Beneficial owner

Sanai Health Industry Group Co Headlines

No Headlines